Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

12.7K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
12.7K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
The Resting Membrane Potential01:21

The Resting Membrane Potential

142.1K
Overview
142.1K
Introduction to Membrane Proteins01:16

Introduction to Membrane Proteins

80.8K
The cell membrane, or plasma membrane, is an ever-changing landscape. It is described as a fluid mosaic where various macromolecules are embedded in the phospholipid bilayer. Among the macromolecules are proteins. The protein content varies across cell types. For example, mitochondrial inner membranes contain ~76% protein content, while myelin contains ~18% protein content. Individual cells contain many types of membrane proteins—red blood cells contain over 50—and different cell...
80.8K
What are Membranes?01:24

What are Membranes?

18.6K
A cell's plasma membrane demarcates the cell's borders and determines the nature of its interaction with the environment. Cells exclude certain substances, take in others, and excrete some others in controlled quantities. The plasma membrane must be flexible to allow certain cells, such as red and white blood cells, to change their shape while passing through narrow capillaries. These are the more obvious plasma membrane functions. In addition, the plasma membrane's surface carries...
18.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Molecules to Amoeboid Movement: A New Way for Understanding the Morphology Through Actin-Binding Proteins.

Biomolecules·2025
Same author

Cancer-Associated Gangliosides as a Therapeutic Target for Host Defense Peptide Mimics.

Langmuir : the ACS journal of surfaces and colloids·2023
Same author

Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease.

Frontiers in aging neuroscience·2023
Same author

An efflux-susceptible antibiotic-adjuvant with systemic efficacy against mouse infections.

Scientific reports·2022
Same author

Mechanistic Studies of Antibiotic Adjuvants Reducing Kidney's Bacterial Loads upon Systemic Monotherapy.

Pharmaceutics·2021
Same author

Directed Assembly of Multi-Walled Nanotubes and Nanoribbons of Amino Acid Amphiphiles Using a Layer-by-Layer Approach.

Chemistry (Weinheim an der Bergstrasse, Germany)·2021

Related Experiment Video

Updated: Jan 26, 2026

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR
08:51

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR

Published on: November 4, 2016

10.1K

Sub-inhibitory membrane damage undermines Staphylococcus aureus virulence.

Ayelet Sarah Hershkovits1, Igor Pozdnyakov1, Ohad Meir1

  • 1Department of Biotechnology and Food Engineering, Technion-Israel Institute of Technology, Haifa, Israel.

Biochimica Et Biophysica Acta. Biomembranes
|April 12, 2019
PubMed
Summary
This summary is machine-generated.

The lipopeptide C10OOc12O enhances plasma antibacterial activity and sensitizes MRSA to oxacillin by disrupting bacterial quorum sensing. This suggests potential for new anti-virulence therapies against Gram-positive bacteria.

Keywords:
Antibiotic resistanceInnate immunityMechanisms of actionPeptidomimeticsProton motive forceSynergism of action

More Related Videos

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

6.8K
Methodology for the Study of Horizontal Gene Transfer in Staphylococcus aureus
10:39

Methodology for the Study of Horizontal Gene Transfer in Staphylococcus aureus

Published on: March 10, 2017

17.3K

Related Experiment Videos

Last Updated: Jan 26, 2026

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR
08:51

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR

Published on: November 4, 2016

10.1K
Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

6.8K
Methodology for the Study of Horizontal Gene Transfer in Staphylococcus aureus
10:39

Methodology for the Study of Horizontal Gene Transfer in Staphylococcus aureus

Published on: March 10, 2017

17.3K

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Gram-positive bacteria (GPB) pose significant health threats.
  • Novel antibacterial agents are crucial for combating resistance.
  • Membrane-active lipopeptides offer a promising therapeutic avenue.

Purpose of the Study:

  • To investigate the antibacterial properties of the lipopeptide C10OOc12O against GPB.
  • To evaluate its synergistic effects with antibiotics and its impact on bacterial virulence.
  • To elucidate the mechanism of action of C10OOc12O.

Main Methods:

  • Minimal inhibitory concentration (MIC) and kinetic assays in culture media and plasma.
  • Checkerboard assay for chemo-sensitization.
  • Membrane potential, ATP levels, and enzyme activity assays.
  • Assessment of quorum sensing-regulated virulence factors.

Main Results:

  • C10OOc12O showed enhanced activity in human plasma compared to culture media.
  • Sub-inhibitory concentrations damaged bacterial membranes, reduced transmembrane potential, and transiently affected ATP levels.
  • C10OOc12O inhibited key virulence factors (lipase, α-toxin) and resensitized methicillin-resistant Staphylococcus aureus (MRSA) USA300 to oxacillin.
  • The lipopeptide affected the quorum sensing regulator, weakening bacterial defenses.

Conclusions:

  • C10OOc12O exhibits potent anti-virulence activity against S. aureus by targeting quorum sensing.
  • Its ability to potentiate antibiotic activity and disrupt virulence factors highlights its therapeutic potential.
  • C10OOc12O represents a promising candidate for novel anti-virulence strategies against GPB infections.